The so-called breast cancer genes BRCA1 and BRCA2 can raise the risk that a man who develops prostate cancer will get an aggressive form of the disease, U.S. researchers reported.

Men who are very sexually active in their twenties and thirties are more likely to develop prostate cancer, especially if they masturbate frequently, according to a study of more than 800 men published in the January issue of BJU International.

High-intensity focused ultrasound (HIFU) represents a minimally invasive approach to treating prostate cancer (CaP). This study out of Italy shows promising early oncological outcomes and a favorable side effect profile. It is presently not FDA approved in the US, but experience with the approach exists in Europe.

Men who are very sexually active in their twenties and thirties are more likely to develop prostate cancer, especially if they masturbate frequently, according to a new study.

Although primary prostate surgery or radiotherapy is successful in many cases of prostate cancer, some patients suffer a recurrence of the disease, which is most often first detected by a measurable PSA blood test — affecting 30 percent to 40 percent of patients after surgery. The presence of cancer potentially outside the prostate after surgery, will affect about a third of men.

A new study appearing in the Prostate has found that certain measles virus vaccine strain derivatives, including a strain known as MV-CEA, may prove to be an effective treatment for patients with advanced prostate cancer.

A new study appearing in The Prostate has found that certain measles virus vaccine strain derivatives, including a strain known as MV-CEA, may prove to be an effective treatment for patients with advanced prostate cancer.

Researchers at the Johns Hopkins University School of Medicine have discovered how a whole class of commonly used chemotherapy drugs can block cancer growth.

One in six American men are diagnosed with prostate cancer within their lifetime and 186,000 will be diagnosed this year. For most men, their disease is confined to the prostate gland, making it easier to treat and less lethal. However, some unfortunate patients suffer from a more aggressive cancer that metastasizes, or spreads beyond the boundaries of the prostate gland.

According to the National Cancer Policy Board, it is estimated that by the year 2050 there will be more cancer survivors in the United States than those newly diagnosed with the disease.